tiprankstipranks
Tryp Therapeutics Inc (TRYPF)
OTHER OTC:TRYPF

Tryp Therapeutics Inc (TRYPF) Technical Analysis

7 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Tryp Therapeutics Inc’s (TRYPF) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Tryp Therapeutics Inc is a Buy.
Tryp Therapeutics Inc’s (TRYPF) 20-Day exponential moving average is 0.02, while Tryp Therapeutics Inc’s (TRYPF) share price is <$0.1, making it a Sell.
Tryp Therapeutics Inc’s (TRYPF) 50-Day exponential moving average is 0.02, while Tryp Therapeutics Inc’s (TRYPF) share price is <$0.1, making it a Sell.

Tryp Therapeutics Inc (TRYPF) Pivot Points

May 04, 2024, 09:42 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.02
0.02
0.02
0.02
0.02
0.02
0.02
Fibonacci
0.02
0.02
0.02
0.02
0.02
0.02
0.02
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Tryp Therapeutics Inc (TRYPF) Moving Averages

May 04, 2024, 09:42 AM
Period
Simple
Exponential
MA5
0.02Sell
0.02Sell
MA10
0.02Sell
0.02Sell
MA20
0.02Sell
0.02Sell
MA50
0.02Sell
0.02Sell
MA100
0.03Sell
0.03Sell
MA200
0.04Sell
0.04Sell
Tryp Therapeutics Inc’s (TRYPF) 10-Day exponential moving average is 0.02, while Tryp Therapeutics Inc’s (TRYPF) share price is <$0.1, making it a Sell.
Tryp Therapeutics Inc’s (TRYPF) 100-Day exponential moving average is 0.03, while Tryp Therapeutics Inc’s (TRYPF) share price is <$0.1, making it a Sell.
Tryp Therapeutics Inc’s (TRYPF) stock price is <$0.1 and Tryp Therapeutics Inc’s (TRYPF) 50-day simple moving average is 0.02, creating a Sell signal.
Tryp Therapeutics Inc’s (TRYPF) stock price is <$0.1 and Tryp Therapeutics Inc’s (TRYPF) 100-day simple moving average is 0.03, creating a Sell signal.
Tryp Therapeutics Inc’s (TRYPF) stock price is <$0.1 and Tryp Therapeutics Inc’s (TRYPF) 200-day simple moving average is 0.04, creating a Sell signal.

Tryp Therapeutics Inc (TRYPF) Technical Indicators

May 04, 2024, 09:42 AM
Name
Value
Implied Action
RSI (14)
44.65
Neutral
STOCH (9,6)
6.67
Buy
STOCHRSI (14)
11.11
Buy
MACD (12,26)
>-0.01
Buy
ADX (14)
11.68
Buy
Williams %R
-91.67
Buy
CCI (14)
-63.57
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
48.75
Neutral
ROC
-21.05
Sell
Tryp Therapeutics Inc’s (TRYPF) Relative Strength Index (RSI) is 44.65, creating a Neutral signal.
Tryp Therapeutics Inc’s (TRYPF) Trend Strength Indicator (ADX) is 11.68, creating a Buy signal.
Tryp Therapeutics Inc’s (TRYPF) Commodity Channel Index (CCI) is -63.57, creating a Neutral signal.
Tryp Therapeutics Inc’s (TRYPF) Price Rate of Change (ROC) is -21.05, creating a Sell signal.

FAQ

Is TRYPF a Buy, Hold, or Sell?
Based on TRYPF’s technical indicators, TRYPF is a Sell.
    What is TRYPF’s RSI (14)?
    TRYPF’s RSI (14) is 44.65, which suggests TRYPF is a Neutral.
      What is TRYPF’s MACD?
      TRYPF’s MACD is >-0.01, which suggests TRYPF is a Buy.
        What is TRYPF’s 5-day moving average?
        TRYPF’s 5-day moving average is 0.02, which suggests TRYPF is a Sell.
          What is TRYPF’s 20-day moving average?
          TRYPF 20-day moving average is 0.02, which suggests TRYPF is a Sell.
            What is TRYPF’s 50-day moving average?
            TRYPF’s 50-day moving average is 0.02, which suggests TRYPF is a Sell.
              What is TRYPF’s 200-day moving average?
              TRYPF’s 200-day moving average is 0.04, which suggests TRYPF is a Sell.
                What is TRYPF’s Williams % R (14)?
                TRYPF’s Williams % R (14) is -91.67, which suggests TRYPF is a Buy.
                  What is TRYPF’s CCI (14)?
                  TRYPF’s CCI (14) is -63.57, which suggests TRYPF is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis